• September 12. Genentech informs healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML). MedWatch Safety Information
• September 5. FDA posts quarterly report of potential safety issues. FDA News
• September 4. FDA announces that manufacturers of TNF-blocker drugs (Cimzia, Enbrel, Humira, and Remicade) must highlight the risk of fungal and serious opportunistic infections. FDA News
• August 25. FDA updates the Information for Healthcare Professionals sheet for Tysabri (natalizumab). Drug Information
Previous News Items
|